Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(1.58)
# 3,252
Out of 4,334 analysts
17
Total ratings
38.5%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.49 | +614.29% | 1 | May 20, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $41.13 | - | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $9.80 | +2.04% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $339.30 | +10.52% | 1 | May 7, 2026 | |
| BIIB Biogen | Upgraded: Buy | $245 | $193.76 | +26.45% | 1 | May 1, 2026 | |
| INGN Inogen | Initiated Coverage: Buy | $12 | $6.40 | +87.50% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiated Coverage: Buy | $16 | $11.92 | +34.23% | 1 | Apr 6, 2026 | |
| GOCO GoHealth | Downgraded: Hold | $1.5 | $0.655 | +129.01% | 1 | Apr 6, 2026 | |
| IRMD IRADIMED CORPORATION | Initiated Coverage: Buy | $116 | $92.10 | +25.95% | 1 | Apr 2, 2026 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $20 | $4.71 | +324.63% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.28 | +163.16% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $16.80 | +120.24% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $5.79 | +89.98% | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $7.99 | +62.70% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $38.22 | -24.12% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $4.19 | n/a | 1 | Mar 18, 2025 |
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.49
Upside: +614.29%
Sionna Therapeutics
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $41.13
Upside: -
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $9.80
Upside: +2.04%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $339.30
Upside: +10.52%
Biogen
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $193.76
Upside: +26.45%
Inogen
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.40
Upside: +87.50%
AngioDynamics
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $11.92
Upside: +34.23%
GoHealth
Apr 6, 2026
Downgraded: Hold
Price Target: $1.5
Current: $0.655
Upside: +129.01%
IRADIMED CORPORATION
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $92.10
Upside: +25.95%
Intensity Therapeutics
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $4.71
Upside: +324.63%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $2.28
Upside: +163.16%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $16.80
Upside: +120.24%
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $5.79
Upside: +89.98%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $7.99
Upside: +62.70%
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $38.22
Upside: -24.12%
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $4.19
Upside: n/a